Subscribe To
Axsome: teva's anda is no surprise and no big deal
Teva filed an ANDA challenge against Auvelity four months after approval. The filing defines, for me, the hurdles ...
February 20, 2023, 11:06 am
Novartis names firmenich ceo as chairman designate of sandoz
Novartis on Monday announced the appointment of Gilbert Ghostine as chairman-designate of Sandoz, the generics...
February 20, 2023, 1:34 am
Hikma pharmaceuticals higher as citi analysts revise target price
Analysts at Citi have revised their net present value (NPV)-based price target for Hikma Pharmaceuticals PLC (LSE:HIK, OTC:HKMPF) to £19.20 with a ...
January 5, 2023, 4:32 am
Novartis to pay $245 mln to end antitrust cases over exforge drug generics
Novartis AG said on Wednesday it will pay $245 million to end antitrust litigation accusing the Swiss drugmaker of trying to delay the launch in the U...
December 28, 2022, 7:46 pm
Analysis-novartis ceo may struggle to rally investors to sandoz spin-off
Novartis CEO Vas Narasimhan could struggle to woo investors to the listing of generics drugs business S...
August 26, 2022, 1:11 am
Sandoz will be a long-term stable business if it can get its cost structure right, novasecta says
John Rountree, managing partner at pharma consultancy Novasecta, discusses Novartis' decision to spin off gene...
August 25, 2022, 6:28 am
Novartis to spin off, list sandoz business
Novartis AG is planning to spin off its generics-and-biosimilars division Sandoz and list it as a stand...
August 25, 2022, 1:53 am
Novartis to spin off sandoz, list it in zurich
Novartis said on Thursday it would spin off Sandoz and list it on the Swiss stock exchange to create the No.1 European ...
August 25, 2022, 1:23 am
Pfizer is a solid high-yielding idea
Pfizer is a high-quality, high-yielding pharmaceutical company backed up by a robust drug portfolio. We appreciate Pfizer's decision to spinoff its Up...
August 11, 2022, 12:50 pm
Amneal pharmaceuticals, inc. (amrx) management team on q1 2022 results - earnings call transcript
Amneal Pharmaceuticals, Inc. (NYSE:AMRX ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Tony DiMeo – Head-Investor Re...
May 4, 2022, 2:04 pm
Novartis posts higher net profit of $2.22 billion on sales of $12.53 billion
Novartis on Tuesday posted rising earnings and sales for the first quarter of the year as its key drugs drove the business and ...
April 26, 2022, 1:39 am
Amarin corp.: hitting the thesis reset button
Amarin has had a rough go of it since the patent ruling in the United States for their flagship product, Vascepa. The company is struggling to maintai...
April 21, 2022, 1:03 am
Amneal pharmaceuticals: generics and biosimilars play has strong upside potential under new / old management
Amneal Pharmaceuticals shares have fallen in value from $24 to $4 since September 2018....
March 30, 2022, 3:26 pm
Amarin (amrn) q4 earnings top, sales hurt by vascepa generics
Amarin's (AMRN) Vascepa sales decline amid rising generic competition and COVID-19 related disruptions during the fourth quarter. The company's stock ...
March 2, 2022, 12:14 pm
Amarin (amrn) q4 earnings top, sales hurt by vascepa generics
Amarin's (AMRN) Vascepa sales decline amid rising generic competition and COVID-19 related disruptions during the fourth quarter. The company's stock ...
March 2, 2022, 12:14 pm
Amarin (amrn) q4 earnings top, sales hurt by vascepa generics
Amarin's (AMRN) Vascepa sales decline amid rising generic competition and COVID-19 related disruptions during the fourth quarter. The company's stock ...
March 2, 2022, 12:14 pm
Teva pharm q4 profit rises, sees more growth in key drugs
Teva Pharmaceutical Industries beat fourth-quarter profit expectations as gains in North American sales of Huntington's disease treatment Austedo and ...
February 9, 2022, 8:02 am
Teva pharm q4 profit rises, sees more growth in key drugs
Teva Pharmaceutical Industries beat fourth-quarter profit expectations as gains in North American sales of Huntington's disease treatment Austedo and ...
February 9, 2022, 8:02 am
Teva pharm q4 profit rises, sees more growth in key drugs
Teva Pharmaceutical Industries beat fourth-quarter profit expectations as gains in North American sales of Huntington's disease treatment Austedo and ...
February 9, 2022, 8:02 am
Novartis (nvs) q4 earnings & sales miss, sandoz review ongoing
Novartis (NVS) reports dismal results for the fourth quarter. Key brands maintain momentum but the generics...
February 2, 2022, 11:33 am